Interpace Biosciences Inc. (IDXG)
IDXG trades on OTC. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/0001493152-26-013646-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | IDXG on OTC |
| Sector | The Nasdaq screener gives no sector |
| Industry | The Nasdaq screener gives no industry |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001054102 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $38.7M |
| Net income | $24.6M |
| Operating income | $4.1M |
| Net margin | 63.5% |
| Operating margin | 10.5% |
| Revenue growth | -17.5% |
| Cash | $2.5M |
| Total assets | $33.8M |
| P/E (computed) | 1.0× |
| P/S (computed) | 0.6× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-08-10 |
| Cash and burn | $2.7M cash; operating cash flow $1.1M a quarter. | Report 2026-06-30 |
| Shares outstanding | 27,700,904 (2026-07-31); 4,423,093 a year earlier; 4,314,216 three years earlier. | Cover page 2026-07-31 |
| Reverse splits, 3 years | 1; latest on 2026-08-27 | Source 2026-08-27 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | EisnerAmper LLP, Philadelphia, Pennsylvania, United States | PCAOB Form AP 2026-03-31 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
| Market cap check | The listing's market cap implies 4,055,593 shares at the 2026-11-13 price; the latest SEC cover count is 27,700,904 as of 2026-07-31. One of the two share counts is stale. | Nasdaq screener and SEC cover page |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $9.1M | $158K | $98K | $2.7M | No debt tags | $36.1M | 10-Q 2026-08-10 |
| Q1 2026 2026-03-31 | $9.0M | $721K | $283K | $2.6M | No debt tags | $36.2M | 10-Q 2026-05-12 |
| Q4 2025 2025-12-31 | $9.2M | $22.7M | $2.1M | $2.5M | $0 | $38.7M | 10-K 2026-03-30 |
| Q3 2025 2025-09-30 | $8.8M | $911K | $1.9M | $1.4M | $2.0M | $41.9M | 10-Q 2025-11-12 |
| Q2 2025 2025-06-30 | $9.2M | -$640K | $520K | $502K | $3.7M | $45.5M | 10-Q 2026-08-10 |
| Q1 2025 2025-03-31 | $11.5M | $1.6M | $1.2M | $1.2M | $5.7M | $48.3M | 10-Q 2026-05-12 |
| Q4 2024 2024-12-31 | $12.4M | $1.9M | $1.2M | $1.5M | $8.7M | $46.9M | 10-K 2026-03-30 |
| Q3 2024 2024-09-30 | $12.3M | $1.7M | $2.1M | $1.4M | $11.6M | $44.6M | 10-Q 2025-11-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1/A | 2026-10-30 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-10-15 |
| Latest proxy | DEFA14A | 2026-07-07 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -13.6% |
| 1 month | +2.5% |
| 3 months | +262.3% |
| Year to date | +391.9% |
| 1 year | +523.7% |
| From 52-week high | -20.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers
No industry from the screener, so peers can't be matched.
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier